Our Stories – Commander Bill Manofsky USN (retd)


American Flag Commander Bill Manofsky USN (retd)

Bill Manofsky

Commander Bill Manofsky USN(ret) served in  Operation Iraqi Freedom. He transfered from China Lake to Ali Al Salem Air Base, Kuwait in Dec 2002 as Officer-in-Charge over a combined civilian and military team that deployed Tactical Dissemination Module (TDM), which enabled transmission of just-in-time target packages from the Combined Air Operations Center (CAOC) in Saudi Arabia directly to tactical aircraft flying in the combat zone. He and the TDM team worked closely with Fleet F-18’s and S-3’s flying off carriers in the Persian Gulf during TDM validation. He also worked closely with the/a Predator Unmanned Aerial Vehicle squadron and coordinated Predator coverage for the SEAL attack on the Al Faw peninsula at the start of the Iraq war.

Under the direction of the Secretary of the Air Force and CENTCOM, Manofsky remained in Kuwait and was assigned to special forces intelligence to perform solo deployment of first prototype version of the Precision Strike Suite Special Operation Forces (PSSSOF) close air support targeting system to Army/Navy/Air Force Special Forces Forward Air Controllers (FACs). This system significantly reduced air-to-ground friendly fire incidents during the Iraq War and is the current standard for Navy SEAL, Army Special Forces, and Air Force FAC CAS missions.

While in Kuwait, Manofsky sustained a permanent brain injury from mefloquine, and was diagnosed with acute and chronic PTSD. He has been instrumental in U.S. advocacy efforts including engagement with the Food and Drug Administration that resulted in the 2013 “black box” warning that mefloquine may cause long term or permanent neurological damage. Bill is also actively involved in supporting US mefloquine veterans receiving appropriate care. Read more about his story here or contact him here.

Advertisements

About IMVAlliance.org

An international network of military veterans, families and friends affected by the health impacts of the neurotoxic antimalarial drug, mefloquine.
This entry was posted in Advocacy, Our Stories and tagged , , . Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s